Preferred Label : Enfuvirtide;

MeSH definition : A synthetic 36-amino acid peptide that corresponds to the heptad repeat sequence of HIV-1 gp41. It blocks HIV cell fusion and viral entry and is used with other anti-retrovirals for combination therapy of HIV INFECTIONS and AIDS.;

MeSH synonym : Pentafuside;

MeSH hyponym : DP178; DP-178; Peptide T20; T20, Peptide;

UNII : 19OWO1T3ZE;

InChIKey : PEASPLKKXBYDKL-FXEVSJAOSA-N;

Details


Main resources

You can consult :

A synthetic 36-amino acid peptide that corresponds to the heptad repeat sequence of HIV-1 gp41. It blocks HIV cell fusion and viral entry and is used with other anti-retrovirals for combination therapy of HIV INFECTIONS and AIDS.

https://ansm.sante.fr/actualites/arret-de-commercialisation-de-lantiretroviral-fuzeon-enfuvirtide
2024
false
false
false
France
French
drug information
Enfuvirtide
enfuvirtide
hiv fusion inhibitors

---
https://pharmacomedicale.org/medicaments/par-specialites/item/autres-antiretroviraux
2016
false
false
false
France
French
drug information
hiv fusion inhibitors
hiv infections
enfuvirtide
maraviroc
CCR5 Receptor Antagonists
Raltegravir Potassium
raltegravir
HIV integrase inhibitors
anti-retroviral agents
peptide fragments
HIV envelope protein gp41
cyclohexanes
triazoles
Enfuvirtide
Maraviroc

---
http://www.has-sante.fr/portail/jcms/c_2561585/fr/fuzeon
http://www.has-sante.fr/portail/jcms/c_1198159/fuzeon
http://www.has-sante.fr/portail/jcms/c_400022/fuzeon-90-mg/ml-poudre-et-solvant-pour-solution-injectable-boite-de-60-flacons-de-poudre-pour-solution-injectable-60-flacons-de-solvant-60-seringues-de-3-ml-60-seringues-de-1ml-et-180-tampons-alcoolises
2015
false
France
French
evaluation of the transparency committee
human immunodeficiency virus i infection
injections, subcutaneous
enfuvirtide
insurance, health, reimbursement
hiv fusion inhibitors
hiv infections
HIV-1
treatment outcome
adult
child
clinical trials as topic
cohort studies
drug therapy, combination
peptide fragments
HIV envelope protein gp41
Enfuvirtide

---
http://www.meddispar.fr/medicaments/3622185
2008
France
French
HIV envelope protein gp41
injections
legislation, drug
drug prescriptions
peptide fragments
enfuvirtide
drug information
Enfuvirtide

---
https://www.ema.europa.eu/medicines/human/EPAR/Fuzeon
2008
United Kingdom
English
French
syndication feed
Contraindications, Procedure
peptide fragments
hiv fusion inhibitors
hiv fusion inhibitors
hiv fusion inhibitors
drug interactions
treatment outcome
drug evaluation, preclinical
pregnancy
breast feeding
drug labeling
drug approval
HIV-1
drug therapy, combination
HIV envelope protein gp41
hiv fusion inhibitors
acquired immunodeficiency syndrome
peptide fragments
peptide fragments
HIV envelope protein gp41
hiv fusion inhibitors
hiv infections
HIV envelope protein gp41
peptide fragments
hiv fusion inhibitors
HIV envelope protein gp41
HIV envelope protein gp41
HIV envelope protein gp41
peptide fragments
peptide fragments
injections, subcutaneous
adult
adolescent
aged
child
powders
enfuvirtide
drug evaluation
summary of product characteristics
package leaflet
Contraindications, Drug
Enfuvirtide

---
https://www.cadth.ca/sites/default/files/pdf/260_enfuvirtide_cetap_f.pdf
2003
Canada
French
acquired immunodeficiency syndrome
hiv infections
acquired immunodeficiency syndrome
hiv infections
peptide fragments
HIV envelope protein gp41
hiv fusion inhibitors
hiv fusion inhibitors
peptide fragments
HIV envelope protein gp41
treatment outcome
canada
clinical trials as topic
HIV envelope protein gp41
hiv fusion inhibitors
peptide fragments
enfuvirtide
peptide fragments
HIV envelope protein gp41
journal article
table
drug evaluation
Enfuvirtide

---
Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.